[go: up one dir, main page]

PT1133283E - Um metodo de producao de particulas de farmaco - Google Patents

Um metodo de producao de particulas de farmaco

Info

Publication number
PT1133283E
PT1133283E PT99963729T PT99963729T PT1133283E PT 1133283 E PT1133283 E PT 1133283E PT 99963729 T PT99963729 T PT 99963729T PT 99963729 T PT99963729 T PT 99963729T PT 1133283 E PT1133283 E PT 1133283E
Authority
PT
Portugal
Prior art keywords
particles
pharmaco
production
susceptible
degradation
Prior art date
Application number
PT99963729T
Other languages
English (en)
Inventor
Boissier Catherine
Juppo Anne Mari
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1133283E publication Critical patent/PT1133283E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/04Solvent extraction of solutions which are liquid
    • B01D11/0403Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT99963729T 1998-11-23 1999-11-22 Um metodo de producao de particulas de farmaco PT1133283E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Publications (1)

Publication Number Publication Date
PT1133283E true PT1133283E (pt) 2005-01-31

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99963729T PT1133283E (pt) 1998-11-23 1999-11-22 Um metodo de producao de particulas de farmaco

Country Status (12)

Country Link
US (1) US6596315B1 (pt)
EP (1) EP1133283B1 (pt)
JP (1) JP4612191B2 (pt)
AT (1) ATE278390T1 (pt)
AU (1) AU754385B2 (pt)
CA (1) CA2349711C (pt)
DE (1) DE69920945T2 (pt)
DK (1) DK1133283T3 (pt)
ES (1) ES2228148T3 (pt)
PT (1) PT1133283E (pt)
SE (1) SE9804003D0 (pt)
WO (1) WO2000030612A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7186796B2 (en) 2002-02-25 2007-03-06 Phasex Corporation Method for drying water-borne materials
ATE551991T1 (de) * 2002-04-15 2012-04-15 Map Pharmaceuticals Inc Formulierung aus feinen teilchen mit verflüssigten oder dichten gasen
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
GB2401547B (en) 2003-05-08 2005-07-20 Nektar Therapeutics Uk Ltd Particulate materials
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1904219A4 (en) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc METHOD FOR FORMING PARTICLES
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
WO1990003782A2 (en) * 1988-10-05 1990-04-19 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
CA2206782C (en) 1994-12-22 2007-04-03 Astra Aktiebolag Aerosol drug formulations
DE69637441T2 (de) * 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer

Also Published As

Publication number Publication date
CA2349711C (en) 2008-07-15
DE69920945T2 (de) 2005-08-25
SE9804003D0 (sv) 1998-11-23
AU754385B2 (en) 2002-11-14
ATE278390T1 (de) 2004-10-15
CA2349711A1 (en) 2000-06-02
JP2002530317A (ja) 2002-09-17
WO2000030612A1 (en) 2000-06-02
EP1133283A1 (en) 2001-09-19
JP4612191B2 (ja) 2011-01-12
DE69920945D1 (de) 2004-11-11
US6596315B1 (en) 2003-07-22
EP1133283B1 (en) 2004-10-06
ES2228148T3 (es) 2005-04-01
DK1133283T3 (da) 2005-01-24
AU2010200A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
PT1133283E (pt) Um metodo de producao de particulas de farmaco
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
MXPA06007171A (es) Derivados de ciclohexano espirociclicos con afinidad para el receptor orl1.
IS5884A (is) Aðferð til framleiðslu á hreinu sítalóprami
ZA200307450B (en) Process for the production of synthesis gas.
NO20051427L (no) Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
TR199800608A3 (tr) Propanolamin türevleri, bunlarin üretim usulü.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
IS7239A (is) Aðferð til framleiðslu á essítalóprami
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
IT1317722B1 (it) Procedimento per la produzione di gas di sintesi.
BR9916460A (pt) Produção de ácido ascórbico usando levedura
IL158400A0 (en) Process for the production of citalopram
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
TR200000441A3 (tr) Organik azitlerin imali için islem.